* Head of industry group urges UK to keep free drug pricing * Talks with government on new system to start shortly * Companies want current system to stay in place until 2014 By Ben Hirschler LONDON, June 9 (Reuters) - Retaining the right to set prices for medicines will be a key goal of drugmakers in coming talks with the British government, as healthcare budgets across Europe come under pressure for savings. A government proposal last month to promote "value-based pricing" triggered concerns...
Full Story: The Guardian
